Citicoline

Randomized trials show improved episodic memory in older adults and better attention at 250-500 mg/day. Effects in healthy young adults are smaller and less consistent.

Citicoline occupies a middle tier of the nootropic world that deserves more attention than it gets: cheaper claims get more marketing, flashier compounds get more forum posts, but citicoline quietly has some of the better randomized-trial support in the category.

Its dual mechanism is what distinguishes it from plain choline supplements. Once absorbed it splits into choline and cytidine; the brain uses the pair to synthesize phosphatidylcholine, the structural phospholipid that neuronal membranes are largely built from, while the choline fraction also supports acetylcholine — the neurotransmitter most tied to attention and memory. You are supplying both a building material and a signaling precursor.

The trial record concentrates in two places. In older adults with age-associated memory decline, randomized controlled trials — including a well-run 2021 study — found improved episodic memory over 12 weeks at 500 mg daily. In attention, trials in both older and younger adults have found measurable improvements at 250-500 mg, though the younger-adult effects are subtler and less consistently replicated. For stroke recovery, where citicoline spent decades as a prescription drug in Europe and Japan, the largest modern trial came back null — worth knowing as context for older enthusiastic claims.

As a practical matter citicoline is easy to use well. The studied doses are 250-500 mg once daily, tolerability in trials has been excellent, and it pairs sensibly with regimens that increase acetylcholine demand. The honest framing: for adults noticing early memory slippage it has genuine, replicated support; for a sharp 25-year-old seeking an edge, expect something between subtle and nothing. That gradient — clear benefit where there is a deficit to repair, diminishing returns at a healthy baseline — is the recurring pattern across evidence-based nootropics, and citicoline illustrates it cleanly.

How it works

Citicoline splits into choline and cytidine, which the brain reassembles into phosphatidylcholine — the main phospholipid of neuronal membranes — while the choline also feeds acetylcholine synthesis. It thus supplies both a neurotransmitter precursor and a membrane-repair substrate in one molecule.